Weight loss by the end of the first month typically ranges from 3-8 pounds, though individual results vary significantly
Peptide therapies are often explored as part of a comprehensive health strategy that may also include nutrition guidance, activity recommendations, and ongoing medical support
The Endocrine Society, whose members include scientists and physicians dedicated to hormone research and treatment for hormone-related conditions, says studies have shown that weight loss medications like semaglutide and tirzepatide improve body composition by reducing excess body fat and increasing the proportion of lean body mass
Months 46: Building Momentum and Lifestyle Integration The 46 month window typically shows cumulative weight loss ranging from 1015% of starting body weight for most patients on consistent tirzepatide therapy
Beyond 12 weeks, continued use maintains effects rather than producing additional benefits
GLP-1 medications are biologics that must stay refrigerated